Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/22/2013 | US20130217577 Novel class of glyphosate resistance genes |
08/22/2013 | US20130217132 Methods, compositions and use for enhancing chemical tolerance by microorganisms |
08/22/2013 | US20130217131 Genome engineering via designed tal effector nucleases |
08/22/2013 | US20130217125 Culture method |
08/22/2013 | US20130217124 Modified silica shell particles, and methods of making and using the same |
08/22/2013 | US20130217121 Modified Cell Lines for Increasing Lentiviral Titers |
08/22/2013 | US20130217117 Pluripotent stem cells obtained by non-viral reprogramming |
08/22/2013 | US20130217116 Peptide II |
08/22/2013 | US20130217098 Production of isoprenoids |
08/22/2013 | US20130217097 Cell with improved secretion mediated by mrga protein or homologue |
08/22/2013 | US20130217095 Chimeric adenoviruses for use in cancer treatment |
08/22/2013 | US20130217080 Microbial production of l-ascorbic acid |
08/22/2013 | US20130217067 Combinatorial DNA Library for Producing Modified N-Glycans In Lower Eukaryotes |
08/22/2013 | US20130217060 Method for the production of 1-butanol |
08/22/2013 | US20130217008 Chimeric promoter molecules for gene expression in prokaryotes |
08/22/2013 | US20130216653 Spore surface display of bioactive molecules |
08/22/2013 | US20130216579 Methods and compostitions for gene editing of a pathogen |
08/22/2013 | US20130216566 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
08/22/2013 | US20130216563 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof |
08/22/2013 | US20130216503 Methods for Generating Cardiomyocytes |
08/22/2013 | US20130216501 Therapeutic methods based on tyrosine-substituted, capsid-modified raav vectors |
08/22/2013 | US20130216500 Method of treating or retarding the development of blindness |
08/22/2013 | US20130216496 Methods for treating tweak-related conditions |
08/22/2013 | US20130213592 Modification of plant lignin content |
08/22/2013 | DE102012101347A1 Verfahren zur Herstellung einer Nukleinsäure- Bibliothek mit mindestens zwei benachbarten variablen Codon- Tripletts A method for preparing a nucleic acid library comprising at least two adjacent variable codon triplets |
08/22/2013 | CA2857560A1 Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen |
08/22/2013 | CA2856891A1 Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen |
08/22/2013 | CA2850380A1 Agents and method for treating inflammation-related conditions and diseases |
08/21/2013 | EP2628802A1 Dna vaccine based on b7-1-pe40kdel exotoxin fusion gene and use thereof |
08/21/2013 | EP2628801A1 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton |
08/21/2013 | EP2628800A1 MicroRNA (miRNA) miR-21 for diagnostic and therapeutic purposes |
08/21/2013 | EP2628799A2 RNAi modulation of RSV and therapeutic uses thereof |
08/21/2013 | EP2628798A1 Prophylactic or therapeutic agent for fibrosis |
08/21/2013 | EP2628797A1 Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain |
08/21/2013 | EP2628794A2 Rationally designed meganucleases with altered sequence specifity and DNA-binding affinity |
08/21/2013 | EP2628786A1 Automated nucleic acid processor and automated nucleic acid processing method using multi function dispensing unit |
08/21/2013 | EP2628752A1 Engineered anti-TSLP antibody |
08/21/2013 | EP2628751A2 Binding members for interleukin-6 and use thereof |
08/21/2013 | EP2628387A1 Lettuce R-genes in coupling phase |
08/21/2013 | EP2627787A2 Quantitative multiplexed identification of nucleic acid targets |
08/21/2013 | EP2627785A2 Soybean plant and seed corresponding to transgenic event mon87712 and methods for detection thereof |
08/21/2013 | EP2627774A2 Recombinant modified vaccinia virus ankara (mva) influenza vaccine |
08/21/2013 | EP2627773A1 Restricted immunoglobulin heavy chain mice |
08/21/2013 | EP2627772A1 Production of plants with improved tolerance to water deficit |
08/21/2013 | EP2627771A1 Methods for altering the reactivity of plant cell walls |
08/21/2013 | EP2627770A2 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders |
08/21/2013 | EP2627769A2 Nucleic acid modulators of clec-2 |
08/21/2013 | EP2627768A1 Small viral rna molecules and uses thereof |
08/21/2013 | EP2627764A1 Algal bio-flocculation by inactivation of photoreceptors |
08/21/2013 | EP2627667A1 Production of plants having improved water-deficit tolerance |
08/21/2013 | EP2627359A1 Expression vector for cholesterol 24 -hydrolase in therapy of huntington' s disease |
08/21/2013 | EP2627353A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine |
08/21/2013 | EP2627351A2 Antigen delivery platforms |
08/21/2013 | EP2627339A1 A modified human u1snrna molecule, a gene encoding for the modified human u1snrna molecule, an expression vector including the gene, and the use thereof in gene therapy |
08/21/2013 | EP2627338A1 Axl receptor tyrosine kinase aptamer inhibitor for use in therapy |
08/21/2013 | EP2627337A1 Egfr aptamer inhibitor for use in therapy and diagnosis |
08/21/2013 | EP2627168A1 Als inhibitor herbicide tolerant beta vulgaris mutants |
08/21/2013 | EP2143437B1 Compositions and methods for the diagnosis and treatment of tumor |
08/21/2013 | CN1981047B Methods for dynamic vector assembly of DNA cloning vector plasmids |
08/21/2013 | CN1909922B Novel flavivirus antigens |
08/21/2013 | CN1774511B Fragmentation-based methods and systems for sequence variation detection and discovery |
08/21/2013 | CN103261430A Targeted perhydrolases |
08/21/2013 | CN103261426A Method for expressing deoxyribonuclease in plants |
08/21/2013 | CN103261425A Viral promoter, truncations thereof, and methods of use |
08/21/2013 | CN103261424A Plants having increased tolerance to herbicides |
08/21/2013 | CN103261423A Methods and compositions using small interfering RNA (siRNA) for nematode control in plants |
08/21/2013 | CN103261422A Drought tolerant plants and related constructs and methods involving genes encoding dtp6 polypeptides |
08/21/2013 | CN103261421A Tobacco with reduced cadmium content |
08/21/2013 | CN103261420A Promoters for expressing genes in a fungal cell |
08/21/2013 | CN103261418A Bispecific aptamers mediating tumour cell lysis |
08/21/2013 | CN103261416A Ligation method employing eukaryotic tRNA ligase |
08/21/2013 | CN103261415A Bioassay method for detecting physiologically active substance |
08/21/2013 | CN103261414A Protein production method |
08/21/2013 | CN103261413A Marker for determination of sensitivity to triplet combination anti-cancer agent |
08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
08/21/2013 | CN103261411A Hepatitis c virus gene |
08/21/2013 | CN103261409A Mannanase, coding gene and production thereof |
08/21/2013 | CN103261403A Recombinant clostridia that fix co2 and co and uses thereof |
08/21/2013 | CN103261399A Composition for preventing inflammations |
08/21/2013 | CN103261231A Chimeric spider silk and uses thereof |
08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
08/21/2013 | CN103261221A Immunological cofilin-1 protein measurement method |
08/21/2013 | CN103261217A Soluble pd-1 variants, fusion constructs, and uses thereof |
08/21/2013 | CN103261216A Modified protein body tags and production methods thereof |
08/21/2013 | CN103261215A Drought tolerant plants and related constructs and methods involving genes encoding mate-efflux polypeptides |
08/21/2013 | CN103260645A Norovirus capsid and rotavirus vp6 protein for use as combined vaccine |
08/21/2013 | CN103260644A Parapoxvirus vectors containing rabies virus antigen |
08/21/2013 | CN103260643A Recombinant ndv antigen and uses thereof |
08/21/2013 | CN103255237A Triple fluorescence quantitative reverse transcription-polymerase chain reaction (RT-PCR) detection kit for H7N9 avian influenza virus |
08/21/2013 | CN103255229A One tube PCR type kit for discriminating and diagnosing goose parvovirus and Muscovy duck parvovirus |
08/21/2013 | CN103255228A Loop-mediated isothermal amplification primer for detecting xanthomonas campestris pv.manihotis and kit |
08/21/2013 | CN103255226A Trichina PCR-DHPLC (Polymerase Chain Reaction-Denaturing High Performance Liquid Chromatography) detection primer as well as kit and detection method |
08/21/2013 | CN103255224A Polymerase chain reaction (PCR) authentication primer and method for distinguishing bradysia odoriphaga larva from bradysia difformis larva |
08/21/2013 | CN103255223A Primer and method for authenticating frankliniella occidentalis by using expressed sequence tag (EST) microsatellite markers |
08/21/2013 | CN103255222A Primers and method for identifying greenhouse trialeurodes vaporariorum and bemisia tabaci by utilizing mitochondria SCAR (sequence characterized amplified regions) marker |
08/21/2013 | CN103255221A Chickpea ascochyta blight fungal molecule detection primer and applications thereof |
08/21/2013 | CN103255214A Primer combination and detection kit for discriminating 33 serotypes of streptococcus suis |
08/21/2013 | CN103255209A Primer combination and kit for detecting human leucocyte HLA-B27 antigenic gene |
08/21/2013 | CN103255206A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
08/21/2013 | CN103255205A Novel fluorescence quantitative PCR method for detecting tea tree ICE1 gene expression characteristics |